Microfluidic Continuous Gradients for Enzyme Inhibitor Characterization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microfluidic systems are limited in their ability to generate continuous concentration gradients, which is essential for characterizing biochemical reactions efficiently, due to technological limitations and challenges in controlling fluid characteristics at the nano-scale, leading to inaccurate data acquisition and high reagent consumption.

Innovation Solution

A method involving a microfluidic system that allows for the simultaneous variation of concentrations of inhibitors, biological molecules, and ligands using continuous concentration gradients, enabling the determination of mechanisms of inhibition, potency, and kinetic constants, while reducing reagent use and improving data quality.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If discrete concentration steps are used in biochemical assays, then the number of measurements is limited by the number of dilution steps, but this approach requires significant time and effort for making discrete dilutions and processing individual reactions

Engineering Contradiction:
Improvethroughput of biochemical measurementsVSAvoidtime required for discrete dilutions and processing
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent implements continuous concentration gradients instead of discrete steps, allowing the system to continuously vary inhibitor concentrations across a range without interruption. This enables simultaneous measurement across multiple concentrations in a single experiment, eliminating the need for sequential discrete dilutions and significantly improving throughput while reducing time consumption.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent transitions from one-dimensional discrete concentration points to a two-dimensional continuous gradient system. By spatially distributing multiple concentration values along a gradient continuum, the system can capture dose-response relationships more comprehensively without requiring multiple separate experiments, thereby increasing productivity without proportional time investment.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Measurement precision

If the number of concentration measurements is increased, then data quality improves, but reagent consumption increases and pipetting errors limit the resolution

Engineering Contradiction:
Improveresolution of concentration measurementsVSAvoidreagent consumption
Core Design Contradiction:
Measurement precisionVSLoss of substance

Solution Approach 1:

The continuous gradient system generates an uninterrupted spectrum of concentrations from a single parent solution, eliminating the need for multiple discrete dilution steps. This approach achieves high measurement precision across many concentration points while consuming minimal reagents, as the entire gradient range is derived from one stock solution rather than requiring separate preparations for each concentration level.

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent changes the physical state of concentration distribution from discrete stepped values to a continuous variable gradient. This parameter transformation allows for infinite resolution within the gradient range without proportionally increasing reagent consumption, as the concentration variation is achieved through controlled mixing ratios rather than sequential dilutions.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If discrete dilution steps are used, then the process is manageable, but pipetting errors limit the resolution of discrete steps

Engineering Contradiction:
Improveresolution of concentration stepsVSAvoidaccuracy of concentration preparation
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The continuous gradient eliminates discrete pipetting steps entirely by generating concentrations through controlled mixing of two parent solutions along a gradient. This continuous process avoids the cumulative pipetting errors that occur in multi-step discrete dilutions, significantly improving both resolution and reliability of concentration preparation without requiring numerous manual operations.

Inventive Principle:
Principle #20Continuity of useful action

Data Source

PatentUS7897330B2Methods for characterizing enzyme inhibitors
Publication Date: 2011.03.01 SMITHKLINE BEECHAM CORP
  • US7897330B2 patent drawing
  • US7897330B2 patent drawing
  • US7897330B2 patent drawing

AI summary

Methods for characterizing a biochemical reaction and analysis of reaction products by establishing continuously variable concentration gradients of one or more reagents of the biochemical reaction are provided. Methods for determining mechanism of inhibition or activation, potency of inhibition or activation, or both of an enzyme inhibitor or activator, respectively, are also provided. The continuously variable concentration gradients can be established in a microfluidic chip.